Correlation Between Unicycive Therapeutics and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Unicycive Therapeutics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Sonnet Biotherapeutics.
Diversification Opportunities for Unicycive Therapeutics and Sonnet Biotherapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Unicycive and Sonnet is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Sonnet Biotherapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.76 times more return on investment than Sonnet Biotherapeutics. However, Unicycive Therapeutics is 1.76 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.02 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.32 per unit of risk. If you would invest 57.00 in Unicycive Therapeutics on November 27, 2024 and sell it today you would earn a total of 0.00 from holding Unicycive Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Unicycive Therapeutics |
| Sonnet Biotherapeutics |
Unicycive Therapeutics and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Sonnet Biotherapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |